Renaissance Technologies - IMMUNIC INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMMUNIC INC
ValueSharesWeighting
Q3 2023$849
+118.3%
577,400
+272.8%
0.00%0.0%
Q2 2023$389
-30.8%
154,900
-59.0%
0.00%0.0%
Q1 2023$562
-99.9%
377,460
+188.9%
0.00%0.0%
Q3 2022$413,000
+308.9%
130,665
+347.5%
0.00%
Q2 2022$101,000
-31.8%
29,200
+74.9%
0.00%
Q3 2021$148,000
-27.8%
16,700
+24.6%
0.00%
Q4 2020$205,000
-68.8%
13,400
-62.1%
0.00%
-100.0%
Q3 2020$657,000
-66.1%
35,400
-77.9%
0.00%
-50.0%
Q2 2020$1,938,000
+371.5%
159,931
+135.4%
0.00%
Q1 2020$411,000
-30.1%
67,931
+12.0%
0.00%
Q4 2019$588,000
+40.0%
60,631
+44.3%
0.00%
Q3 2019$420,000
+167.5%
42,029
+206.1%
0.00%
Q2 2019$157,00013,7290.00%
Other shareholders
IMMUNIC INC shareholders Q4 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,788,160$2,628,5952.41%
Gratus Capital, LLC 1,686,455$2,479,0890.17%
INNOVIS ASSET MANAGEMENT LLC 272,457$400,5120.15%
Parkman Healthcare Partners LLC 562,506$826,8840.15%
RTW INVESTMENTS, LP 4,335,255$6,372,8250.13%
Logos Global Management LP 421,184$619,1400.08%
Ikarian Capital, LLC 450,000$661,5010.08%
BVF INC/IL 1,149,425$1,689,6550.05%
Soleus Capital Management, L.P. 300,000$441,0000.04%
COWEN AND COMPANY, LLC 317,059$466,0760.03%
View complete list of IMMUNIC INC shareholders